Health
Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers – News-Medical.Net
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly…
It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global…
-
Noosa News18 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News21 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards
-
Noosa News19 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News21 hours agoHelicopter scrambles to site of air crash on K’gari